This content is machine translated Non-small cell lung cancer CheckMate 057 with promising results Patients with advanced non-squamous type non-small cell lung cancer (NSCLC) benefit from nivolumab after failed platinum-containing chemotherapy. This is the conclusion of the CheckMate 057 study. The tested substance was…
View Post 4 min This content is machine translated News from dermatooncology Melanoma with or without BRAF mutation – new therapies in the pipeline Data from two phase III trials (both from the research group led by Caroline Robert, MD, Institut Gustave Roussy in Villejuif, Paris) published earlier this year highlight the rapid development…
